| Basics |
Capricor Therapeutics, Inc.
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
|
| IPO Date: |
March 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$452.51M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 3.95%
|
| Avg Daily Range (30 D): |
$0.69 | 6.21%
|
| Avg Daily Range (90 D): |
$0.64 | 5.86%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.64M |
| Avg Daily Volume (30 D): |
3M |
| Avg Daily Volume (90 D): |
2.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
186 |
| Avg Trade Size (Sh.) (30 D): |
128 |
| Avg Trade Size (Sh.) (90 D): |
108 |
| Institutional Trades |
| Total Inst.Trades: |
305 |
| Avg Inst. Trade: |
$1.36M |
| Avg Inst. Trade (30 D): |
$1.07M |
| Avg Inst. Trade (90 D): |
$1.14M |
| Avg Inst. Trade Volume: |
.12M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.5M |
| Avg Closing Trade (30 D): |
$1.23M |
| Avg Closing Trade (90 D): |
$1.25M |
| Avg Closing Volume: |
127.31K |
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.53
|
$-.11
|
$-1.15
|
|
Diluted EPS
|
$-.53
|
$-.11
|
$-1.15
|
|
Revenue
|
$ M
|
$ 11.13M
|
$ 22.27M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -24.39M
|
$ -7.12M
|
$ -40.47M
|
|
Operating Income / Loss
|
$ -24.98M
|
$ -7.7M
|
$ -42.56M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 17.51M
|
$ -57.09M
|
$ -3.41M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jun 05, 2019:
1:10
|
|
Nov 21, 2013:
1:50
|
|
Feb 09, 2007:
1:10
|
|
Apr 05, 2005:
1:20
|
|
|
|
